Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221).
Breast Cancer Research And Treatment
Sucheston, Lara E LE; Zhao, Hua H; Yao, Song S; Zirpoli, Gary G; Liu, Song S; Barlow, William E WE; Moore, Halle C F HC; Thomas Budd, G G; Hershman, Dawn L DL; Davis, Warren W; Ciupak, Gregory L GL; Stewart, James A JA; Isaacs, Claudine C; Hobday, Timothy J TJ; Salim, Muhammad M; Hortobagyi, Gabriel N GN; Gralow, Julie R JR; Livingston, Robert B RB; Albain, Kathy S KS; Hayes, Daniel F DF; Ambrosone, Christine B CB
The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies.
Bmc Genetics
Pereira, Lutécia H Mateus LH; Pineda, Marbin A MA; Rowe, William H WH; Fonseca, Libia R LR; Greene, Mark H MH; Offit, Kenneth K; Ellis, Nathan A NA; Zhang, Jinghui J; Collins, Andrew A; Struewing, Jeffery P JP